Polyarthritis: Difference between revisions
No edit summary |
No edit summary |
||
Line 46: | Line 46: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ||
|- | |- | ||
! rowspan=" | ! rowspan="21" style="background: #DCDCDC; padding: 5px; text-align: center;" |Polyarthritis | ||
! rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious arthritis]] | ! rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Infectious arthritis]] | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lyme disease]]<ref name="pmid25999227">{{cite journal| author=Lantos PM| title=Chronic Lyme disease. | journal=Infect Dis Clin North Am | year= 2015 | volume= 29 | issue= 2 | pages= 325-40 | pmid=25999227 | doi=10.1016/j.idc.2015.02.006 | pmc=4477530 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25999227 }}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lyme disease]]<ref name="pmid25999227">{{cite journal| author=Lantos PM| title=Chronic Lyme disease. | journal=Infect Dis Clin North Am | year= 2015 | volume= 29 | issue= 2 | pages= 325-40 | pmid=25999227 | doi=10.1016/j.idc.2015.02.006 | pmc=4477530 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25999227 }}</ref> | ||
Line 346: | Line 346: | ||
! style="background: #F5F5F5; padding: 5px;" |[[Ocular|Ocular involvement]] | ! style="background: #F5F5F5; padding: 5px;" |[[Ocular|Ocular involvement]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Behçet's disease|Behçet's syndrome]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Behçet's disease|Behçet's syndrome]]<ref name="pmid20121672">{{cite journal |vauthors=Sugawara S, Ehara S, Hitachi S, Sugimoto H |title=Hand and wrist arthritis of Behçet disease: imaging features |journal=Acta Radiol |volume=51 |issue=2 |pages=183–6 |date=March 2010 |pmid=20121672 |doi=10.3109/02841850903401349 |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 353: | Line 353: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Erythema nodosum]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Normocytic normochromic anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Serum [[complement]] levels, [[Human leukocyte antigen]] (HLA)-B51 | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Soft tissue swelling | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Non-erosive [[synovitis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Dermal vessels infiltration with lymphocytes and plasma cells, [[Immune]] deposits of [[Immunoglobulin M|immunoglobulin M (IgM)]] and [[C3]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clinical findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Oral ulcer]], [[Mucosal]] erosion | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Relapsing polychondritis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Relapsing polychondritis]]<ref name="pmid27708954">{{cite journal| author=Emmungil H, Aydın SZ| title=Relapsing polychondritis. | journal=Eur J Rheumatol | year= 2015 | volume= 2 | issue= 4 | pages= 155-159 | pmid=27708954 | doi=10.5152/eurjrheum.2015.0036 | pmc=5047229 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27708954 }}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 372: | Line 372: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]], [[Anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Cryoglobulins]], [[ANA]], [[C-ANCA]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Tracheal stenosis]] in [[CXR]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Calcification]] of [[Cartilaginous|cartilaginous structures]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Aortic root|Aortic root dilatation]] and degree of [[aortic regurgitation]] in [[echocardiography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Chondrolysis, [[Chondritis]], Perichondritis | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clinical findings coupled with imaging | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Ear pain]] and redness, [[Polyarthritis]] | ||
|- | |- | ||
! rowspan=" | ! rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Other systemic illnesses''' | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sarcoidosis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Sarcoidosis]]<ref name="pmid18032765">{{cite journal |vauthors=Iannuzzi MC, Rybicki BA, Teirstein AS |title=Sarcoidosis |journal=N. Engl. J. Med. |volume=357 |issue=21 |pages=2153–65 |date=November 2007 |pmid=18032765 |doi=10.1056/NEJMra071714 |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 392: | Line 392: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[papules]] and [[nodules]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" | [[IL-2]] and [[Interferon gamma|IFN-γ]], ↑[[Angiotensin-converting enzyme|ACE]], ↑[[Vitamin D|1, 25-dihydroxyvitamin D]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Bilateral [[Adenopathy|hilar adenopathy]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Active [[alveolitis]] or [[fibrosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Hepatosplenomegaly]] in [[ultrasonography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Granuloma|Noncaseating granulomas (NCGs)]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Histopathology|Histological confirmation]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Heart block]], [[Ocular disease|Ocular lesion]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Palindromic rheumatism]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Palindromic rheumatism]]<ref name="pmid21206416">{{cite journal |vauthors=Iyer VR, Cohen GL |title=Palindromic rheumatism |journal=South. Med. J. |volume=104 |issue=2 |pages=147–9 |date=February 2011 |pmid=21206416 |doi=10.1097/SMJ.0b013e318200c4cc |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 411: | Line 411: | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Rheumatoid nodules]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |High [[WBC]] count (5000-15,000/µL) with >50% of [[PMN|PMN leukocytes]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[RF]], [[Anti-citrullinated protein antibody|Anti-CCP antibody]], ↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | ↑[[ALT]] or [[AST]], [[ANA]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Joint (anatomy)|Effusions in joints]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Fractures|Microfractures]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Basilar invagination with [[cranial]] migration of an eroded [[Odontoid process|odontoid]] peg in [[MRI]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Influx of [[inflammatory cells]] into the [[synovial membrane]], with[[angiogenesis]], proliferation of chronic [[inflammatory cells]] | ||
! style="background: #F5F5F5; padding: 5px;" |Clinical findings coupled [[Anti-citrullinated protein antibody|anti-CCP antibody]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Rheumatoid nodules]] | |||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial mediterranean fever|Familial Mediterranean fever]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Familial mediterranean fever|Familial Mediterranean fever]]<ref name="pmid25610168">{{cite journal| author=Yildirim K, Uzkeser H, Uyanik A, Karatay S, Kiziltunc A| title=Trace element levels in patients with familial mediterranean Fever. | journal=Eurasian J Med | year= 2011 | volume= 43 | issue= 2 | pages= 79-82 | pmid=25610168 | doi=10.5152/eajm.2011.18 | pmc=4261345 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25610168 }}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
Line 430: | Line 432: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |A well-demarcated, [[erythematous]], warm [[rash]], particularly below the [[knee]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell counts as high as 100,000/µL | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[CRP]], [[Amyloid bodies|Amyloid A protein]], [[Fibrinogen]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial inflammation|Synovial effusions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Pleural effusions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Air-fluid levels in [[MRI]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Massive [[amyloid]] infiltration of the [[blood vessels]] and [[endothelial]] side of the [[glomerular basement membrane]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clinical findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Abdominal pain]], [[Myalgia|Severe myalgia]], [[Scrotal swelling|Scrotal attacks]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[ | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyperlipoproteinemia|Hyperlipoproteinemias]]<ref name="SoubrierDubost2009">{{cite journal|last1=Soubrier|first1=Martin|last2=Dubost|first2=Jean Jacques|last3=Thiéblot|first3=Philippe|last4=Ristori|first4=Jean Michel|title=Oligo-arthritis and type IV hyperlipoproteinemia|journal=Joint Bone Spine|volume=76|issue=1|year=2009|pages=95–97|issn=1297319X|doi=10.1016/j.jbspin.2008.03.009}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Xanthelasma]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Xanthochromic]] fluid with [[mononuclear cells]] predominance | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[CRP]], [[Hyperlipidemia (patient information)|Hyperlipidemia]] | ||
! style="background: #F5F5F5; padding: 5px;" |Joint space narrowing | |||
! style="background: #F5F5F5; padding: 5px;" |[[Achilles tendon]] [[enthesitis]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Retrocalcaneal bursitis]] and ill-defined [[edema]] in posterosuperior corner of the [[calcaneus]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Inflammatory]] infiltration | |||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Laboratory findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Atherosclerosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | |||
|- | |- | ||
! rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |Polyarticular pain | ! rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: center;" |Polyarticular pain | ||
! rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Viral arthritis | ! rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Viral arthritis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatitis B]] and [[Hepatitis C|C]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatitis B]] and [[Hepatitis C|C]]'''<ref name="GanemPrince2004">{{cite journal|last1=Ganem|first1=Don|last2=Prince|first2=Alfred M.|title=Hepatitis B Virus Infection — Natural History and Clinical Consequences|journal=New England Journal of Medicine|volume=350|issue=11|year=2004|pages=1118–1129|issn=0028-4793|doi=10.1056/NEJMra031087}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
Line 489: | Line 472: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Urticaria|Urticarial]] and [[maculopapular]] [[Eruption|eruptions]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell counts < 100,000/µL | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[LFTs|LFT]], [[HBsAg]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Joint space narrowing | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Deposition of [[immune complexes]], [[Cryoprecipitate|Cryoprecipitates]] containing [[HBsAg]] and [[Complement|complements]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[HBsAg]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Liver failure]], [[Jaundice|Icterus]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Rubella]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Rubella]]'''<ref name="pmid849368">{{cite journal |vauthors=Spruance SL, Metcalf R, Smith CB, Griffiths MM, Ward JR |title=Chronic arthropathy associated with rubella vaccination |journal=Arthritis Rheum. |volume=20 |issue=2 |pages=741–7 |date=March 1977 |pmid=849368 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
Line 508: | Line 491: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Acute [[maculopapular rash]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Leukocytosis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Rubella virus|Rubella virus antigen]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[LFTs|LFT]], [[CRP]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Joint space narrowing | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |proliferation of the [[Synovial membrane|synovial lining cells]], without [[Inflammatory cells|inflammatory]] | ||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | [[Inflammatory cells|cells]] | ||
! style="background: #F5F5F5; padding: 5px;" |[[Serological testing|Serological evidence]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Headache]], [[Malaise]] | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Parvovirus]]''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Parvovirus]]'''<ref name="pmid10910181">{{cite journal |vauthors=Moore TL |title=Parvovirus-associated arthritis |journal=Curr Opin Rheumatol |volume=12 |issue=4 |pages=289–94 |date=July 2000 |pmid=10910181 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
! style="background: #F5F5F5; padding: 5px;" |+ | ! style="background: #F5F5F5; padding: 5px;" |+ | ||
Line 527: | Line 512: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Fifth disease]]/ [[Erythema infectiosum]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Aplastic crisis]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[ANA]], [[RF]], [[CRP]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Joint swelling | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Immune complex|Immune complex deposition]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Parvovirus|Parvovirus IgM antibody]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Transient [[aplastic crisis]], [[Fetal]] [[infection]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fibromyalgia]] | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Fibromyalgia]]<ref name="pmid23213512">{{cite journal| author=Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE et al.| title=Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. | journal=Pain Res Treat | year= 2012 | volume= 2012 | issue= | pages= 426130 | pmid=23213512 | doi=10.1155/2012/426130 | pmc=3503476 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23213512 }}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 546: | Line 531: | ||
! style="background: #F5F5F5; padding: 5px;" |+/- | ! style="background: #F5F5F5; padding: 5px;" |+/- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Maculopapular rash]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[inflammation]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clinical findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Muscle pain]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Soft tissue abnormalities | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Soft tissue abnormalities | ||
Line 565: | Line 550: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |+/- | ! style="background: #F5F5F5; padding: 5px;" |+/- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Maculopapular rash]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[CRP]], [[Ca]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Joint swelling | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Synovial]] [[edema]] and thickness | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild joint effusion in [[ultrasonography]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[inflammation]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clinical findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Mucositis]], [[Enthesitis]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypothyroidism]] | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypothyroidism]]<ref name="pmid7740308">{{cite journal |vauthors=McLean RM, Podell DN |title=Bone and joint manifestations of hypothyroidism |journal=Semin. Arthritis Rheum. |volume=24 |issue=4 |pages=282–90 |date=February 1995 |pmid=7740308 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | |||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 583: | Line 569: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |Dry and coarse [[skin]] | |||
! style="background: #F5F5F5; padding: 5px;" |[[Anemia]] | |||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Clear yellow fluid with normal cell counts | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[TSH]], [[T4]], [[T3]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Peri-[[articular]] demineralization | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Destructive changes in the [[cartilage]] and [[bone]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |High-signal fluid in the [[joint]] space in [[MRI]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Growth plate|Physeal growth plate]] with little evidence of [[cartilage]] cellular proliferation | ||
! style="background: #F5F5F5; padding: 5px;" |[[TSH]], [[T4]], [[T3]] | |||
! style="background: #F5F5F5; padding: 5px;" |Decreased [[Deep tendon reflex|DTR]], [[Fatigue]] | |||
! style="background: #F5F5F5; padding: 5px;" | | |||
! style="background: #F5F5F5; padding: 5px;" | | |||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neuropathic pain]] | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neuropathic pain]]<ref name="pmid23592730">{{cite journal |vauthors=Magrinelli F, Zanette G, Tamburin S |title=Neuropathic pain: diagnosis and treatment |journal=Pract Neurol |volume=13 |issue=5 |pages=292–307 |date=October 2013 |pmid=23592730 |doi=10.1136/practneurol-2013-000536 |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | |||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 602: | Line 588: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |[[Livedo reticularis]] | |||
! style="background: #F5F5F5; padding: 5px;" |Normal | |||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Hyperglycemia]], [[Hypokalemia]], [[Hypocalcemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Neurologic]] examination | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Paresthesia]], [[Dysesthesia]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Metabolic bone disease | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Metabolic bone disease<ref name="pmid17002489">{{cite journal |vauthors=Skowrońska-Jóźwiak E, Lorenc RS |title=Metabolic bone disease in children : etiology and treatment options |journal=Treat Endocrinol |volume=5 |issue=5 |pages=297–318 |date=2006 |pmid=17002489 |doi= |url=}}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 622: | Line 607: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Hyperpigmentation]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Mild [[anemia]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |↑ | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Cell count < 25% [[PMNs]] (non-[[inflammatory]]) | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Vitamin D]], [[PTH]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Peri-[[articular]] demineralization | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Fracture|Microfractures]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Subperiosteal|Subperiosteal reaction]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Decrease [[mineralization]] of [[bone matrix]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Laboratory findings | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Bone pain]], [[Constipation]] | ||
|- | |- | ||
! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Depression]] | ! colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Depression]]<ref name="pmid16001092">{{cite journal| author=Trivedi MH| title=The link between depression and physical symptoms. | journal=Prim Care Companion J Clin Psychiatry | year= 2004 | volume= 6 | issue= Suppl 1 | pages= 12-6 | pmid=16001092 | doi= | pmc=486942 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16001092 }}</ref> | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
Line 641: | Line 626: | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" |- | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |Normal | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |- | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Psychological analysis|Psychological interview]] | ||
! style="background: #F5F5F5; padding: 5px;" | | ! style="background: #F5F5F5; padding: 5px;" |[[Psychomotor retardation|Slow psychomotor]], [[Muscle pain]] | ||
|- | |- | ||
|} | |} |
Revision as of 19:01, 30 April 2018
Template:DiseaseDisorder infobox
WikiDoc Resources for Polyarthritis |
Articles |
---|
Most recent articles on Polyarthritis Most cited articles on Polyarthritis |
Media |
Powerpoint slides on Polyarthritis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Polyarthritis at Clinical Trials.gov Trial results on Polyarthritis Clinical Trials on Polyarthritis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Polyarthritis NICE Guidance on Polyarthritis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Polyarthritis Discussion groups on Polyarthritis Patient Handouts on Polyarthritis Directions to Hospitals Treating Polyarthritis Risk calculators and risk factors for Polyarthritis
|
Healthcare Provider Resources |
Causes & Risk Factors for Polyarthritis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Polyarthritis is any type of arthritis which involves five or more joints - an inflammation of two, three or four joints is an oligoarthritis.
Causes
Polyarthritis is most often caused by an auto-immune disorder such as Rheumatoid arthritis, Psoriatic arthritis, and Lupus erythematosus but can also be caused by infections such as Ross River Virus.
Differential Diagnosis of Diseases That Cause Polyarthritis
References
- ↑ Lantos PM (2015). "Chronic Lyme disease". Infect Dis Clin North Am. 29 (2): 325–40. doi:10.1016/j.idc.2015.02.006. PMC 4477530. PMID 25999227.
- ↑ Soor P, Sharma N, Rao C (2017). "Multifocal Septic Arthritis Secondary to Infective Endocarditis: A Rare Case Report". J Orthop Case Rep. 7 (1): 65–68. doi:10.13107/jocr.2250-0685.692. PMC 5458702. PMID 28630844.
- ↑ Kumar RK, Tandon R (2013). "Rheumatic fever & rheumatic heart disease: the last 50 years". Indian J Med Res. 137 (4): 643–58. PMC 3724245. PMID 23703332.
- ↑ Colmegna I, Cuchacovich R, Espinoza LR (2004). "HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations". Clin Microbiol Rev. 17 (2): 348–69. PMC 387405. PMID 15084505.
- ↑ Hill Gaston, J (2003). "Arthritis associated with enteric infection". Best Practice & Research Clinical Rheumatology. 17 (2): 219–239. doi:10.1016/S1521-6942(02)00104-3. ISSN 1521-6942.
- ↑ McVeigh CM, Cairns AP (2006). "Diagnosis and management of ankylosing spondylitis". BMJ. 333 (7568): 581–5. doi:10.1136/bmj.38954.689583.DE. PMC 1570004. PMID 16974012.
- ↑ Sankowski AJ, Lebkowska UM, Cwikła J, Walecka I, Walecki J (2013). "Psoriatic arthritis". Pol J Radiol. 78 (1): 7–17. doi:10.12659/PJR.883763. PMC 3596149. PMID 23493653.
- ↑ Orchard TR (2012). "Management of arthritis in patients with inflammatory bowel disease". Gastroenterol Hepatol (N Y). 8 (5): 327–9. PMC 3424429. PMID 22933865.
- ↑ Heidari B (2011). "Rheumatoid Arthritis: Early diagnosis and treatment outcomes". Caspian J Intern Med. 2 (1): 161–70. PMC 3766928. PMID 24024009.
- ↑ Reginato A, Paul H, Schumacher HR (September 1982). "Crystal-induced arthritis". Arch Phys Med Rehabil. 63 (9): 401–8. PMID 6287963.
- ↑ Manson JJ, Rahman A (2006). "Systemic lupus erythematosus". Orphanet J Rare Dis. 1: 6. doi:10.1186/1750-1172-1-6. PMC 1459118. PMID 16722594.
- ↑ Watts RA, Scott DG (October 2016). "Vasculitis and inflammatory arthritis". Best Pract Res Clin Rheumatol. 30 (5): 916–931. doi:10.1016/j.berh.2016.10.008. PMID 27964796.
- ↑ Avouac, J.; Clements, P. J.; Khanna, D.; Furst, D. E.; Allanore, Y. (2012). "Articular involvement in systemic sclerosis". Rheumatology. 51 (8): 1347–1356. doi:10.1093/rheumatology/kes041. ISSN 1462-0324.
- ↑ Briemberg HR, Amato AA (September 2003). "Dermatomyositis and Polymyositis". Curr Treat Options Neurol. 5 (5): 349–356. PMID 12895397.
- ↑ Kadavath S, Efthimiou P (February 2015). "Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options". Ann. Med. 47 (1): 6–14. doi:10.3109/07853890.2014.971052. PMID 25613167.
- ↑ Sugawara S, Ehara S, Hitachi S, Sugimoto H (March 2010). "Hand and wrist arthritis of Behçet disease: imaging features". Acta Radiol. 51 (2): 183–6. doi:10.3109/02841850903401349. PMID 20121672.
- ↑ Emmungil H, Aydın SZ (2015). "Relapsing polychondritis". Eur J Rheumatol. 2 (4): 155–159. doi:10.5152/eurjrheum.2015.0036. PMC 5047229. PMID 27708954.
- ↑ Iannuzzi MC, Rybicki BA, Teirstein AS (November 2007). "Sarcoidosis". N. Engl. J. Med. 357 (21): 2153–65. doi:10.1056/NEJMra071714. PMID 18032765.
- ↑ Iyer VR, Cohen GL (February 2011). "Palindromic rheumatism". South. Med. J. 104 (2): 147–9. doi:10.1097/SMJ.0b013e318200c4cc. PMID 21206416.
- ↑ Yildirim K, Uzkeser H, Uyanik A, Karatay S, Kiziltunc A (2011). "Trace element levels in patients with familial mediterranean Fever". Eurasian J Med. 43 (2): 79–82. doi:10.5152/eajm.2011.18. PMC 4261345. PMID 25610168.
- ↑ Soubrier, Martin; Dubost, Jean Jacques; Thiéblot, Philippe; Ristori, Jean Michel (2009). "Oligo-arthritis and type IV hyperlipoproteinemia". Joint Bone Spine. 76 (1): 95–97. doi:10.1016/j.jbspin.2008.03.009. ISSN 1297-319X.
- ↑ Ganem, Don; Prince, Alfred M. (2004). "Hepatitis B Virus Infection — Natural History and Clinical Consequences". New England Journal of Medicine. 350 (11): 1118–1129. doi:10.1056/NEJMra031087. ISSN 0028-4793.
- ↑ Spruance SL, Metcalf R, Smith CB, Griffiths MM, Ward JR (March 1977). "Chronic arthropathy associated with rubella vaccination". Arthritis Rheum. 20 (2): 741–7. PMID 849368.
- ↑ Moore TL (July 2000). "Parvovirus-associated arthritis". Curr Opin Rheumatol. 12 (4): 289–94. PMID 10910181.
- ↑ Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE; et al. (2012). "Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment". Pain Res Treat. 2012: 426130. doi:10.1155/2012/426130. PMC 3503476. PMID 23213512.
- ↑ McLean RM, Podell DN (February 1995). "Bone and joint manifestations of hypothyroidism". Semin. Arthritis Rheum. 24 (4): 282–90. PMID 7740308.
- ↑ Magrinelli F, Zanette G, Tamburin S (October 2013). "Neuropathic pain: diagnosis and treatment". Pract Neurol. 13 (5): 292–307. doi:10.1136/practneurol-2013-000536. PMID 23592730.
- ↑ Skowrońska-Jóźwiak E, Lorenc RS (2006). "Metabolic bone disease in children : etiology and treatment options". Treat Endocrinol. 5 (5): 297–318. PMID 17002489.
- ↑ Trivedi MH (2004). "The link between depression and physical symptoms". Prim Care Companion J Clin Psychiatry. 6 (Suppl 1): 12–6. PMC 486942. PMID 16001092.